See the DrugPatentWatch profile for cosentyx

There are several medications available that can help manage psoriatic arthritis, similar to Cosentyx. These medications belong to a class of drugs known as biologics, which are designed to target specific parts of the immune system to reduce inflammation. Here are some of the other medications that control psoriatic arthritis like Cosentyx:

1. Enbrel (etanercept): Enbrel is a tumor necrosis factor (TNF) inhibitor that works by blocking the activity of TNF, a substance in the body that can cause inflammation and joint damage. Enbrel is administered as a subcutaneous injection and is usually given once or twice a week.
2. Humira (adalimumab): Humira is another TNF inhibitor that is used to treat psoriatic arthritis. It is given as a subcutaneous injection every other week. Humira works by blocking the action of TNF, which helps reduce inflammation and joint pain.
3. Remicade (infliximab): Remicade is a TNF inhibitor that is administered intravenously. It is usually given every 8 weeks. Remicade works by neutralizing TNF, which helps reduce inflammation and joint damage.
4. Stelara (ustekinumab): Stelara is an interleukin-12 and -23 inhibitor that is used to treat psoriatic arthritis. It is given as a subcutaneous injection every 12 weeks. Stelara works by blocking the action of interleukin-12 and -23, which are proteins that play a role in inflammation.
5. Otezla (apremilast): Otezla is a phosphodiesterase 4 (PDE4) inhibitor that is used to treat psoriatic arthritis. It is taken orally, twice a day. Otezla works by reducing inflammation and joint pain.

It is important to note that each medication has its own benefits and risks, and the choice of medication will depend on the individual patient's needs and medical history. Patients should consult with their healthcare provider to determine the best treatment option for them.

Sources:

* <https://www.drugs.com/condition/psoriatic-arthritis.html>
* <https://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/diagnosis-treatment/drc-20354073>
* <https://www.drugpatentwatch.com/therapeutic-areas/psoriatic-arthritis>